Report #2862016

Received Sep 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: CT
Recovered: Unknown
Vaccinated: Sep 15, 2025
Onset: Sep 15, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	2018414	—

Symptoms (3)

Exposure during pregnancyNo adverse eventProduct use issue

Symptom narrative

The patient has not report any medical concerns or symptoms after being administered the dose of GARDASIL 9; A patient who was 8 months pregnant was administered their first dose of GARDASIL 9 on 9/15/2025; This spontaneous report was received from a nurse prescriber and refers to an 8-months pregnant female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-Sep-2025, the patient received the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #2018414, expiration date: 11-Dec-2025) 0.5 mL, two or three dose series, for prophylaxis (Exposure during pregnancy). The healthcare worker who administered the dose was not aware the patient was pregnant. The patient had not reported any medical concerns or symptoms after being administered the dose of vaccine.